LAG-3 is an immunoinhibitory transmembrane protein comprised of key components, including four immunoglobulin superfamily domains in the extracellular region, a transmembrane domain, and serine phosphorylation sites in the intracellular domain. Functionally, LAG-3 primarily interacts with ligands such as MHC II and galectin-3 to suppress T cell activation and cytokine secretion, thereby maintaining immune homeostasis. In terms of signaling, LAG-3 engagement with its ligands triggers intracellular interactions with downstream signaling molecules, modulating the activation state of T cells. In cancer immunotherapy, LAG-3 serves as a crucial target, and blocking or inhibiting LAG-3 can potentiate T cell-mediated tumor killing. Therefore, elucidating the structure, function, and signaling pathways of LAG-3 holds significant promise for the development of novel immunotherapy strategies.
Recombinant Human Lymphocyte activation gene 3 protein (LAG3), partial (Active) (CSB-MP012719HU3)
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Activity
Measured by its binding ability in a functional ELISA. Immobilized Human LAG3 at 2 μg/ml can bind Anti-LAG3 recombinant antibody(CSB-RA012719MA1HU). The EC50 is 2.306-2.731 ng/mL.
LAG3 Recombinant Monoclonal Antibody (CSB-RA012719MA1HU)
Validated Data
IHC image of CSB-RA012719MA1HU diluted at 1:100 and staining in paraffin-embedded human testis tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-human polymer IgG labeled by HRP and visualized using 0.05% DAB.
The Binding Activity of Human LAG3 with Anti-LAG3 Recombinant Antibody
Activity: Measured by its binding ability in a functional ELISA. Immobilized Human LAG3(CSB-MP012719HU3) at 2 μg/mL can bind Anti-LAG3 recombinant antibody. The EC50 is 2.306-2.731 ng/mL.
Human Lymphocyte activation gene 3 protein(LAG3) ELISA kit (CSB-EL012719HU)
Validated Data
Code: CSB-EL012719HU
Size: 96T,5×96T,10×96T
Sensitivity: 0.039 ng/mL
Detection Range: 0.156 ng/mL-10 ng/mL
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
The following LAG3 reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
LAG3 Antibodies for Homo sapiens (Human)
Code | Product Name | Species Reactivity | Application |
---|---|---|---|
CSB-PA012719GA01HU | LAG3 Antibody | Human,Mouse | ELISA,WB |
CSB-PA012719LA01HU | LAG3 Antibody | Human | ELISA, WB, IF |
CSB-PA012719LC01HU | LAG3 Antibody, FITC conjugated | Human | |
CSB-PA012719LD01HU | LAG3 Antibody, Biotin conjugated | Human | ELISA |
CSB-PA005868 | LAG3 Antibody | Human | WB, ELISA |
CSB-PA172061 | LAG3 Antibody | Human | ELISA,WB |
CSB-MA012719A0m | LAG3 Monoclonal Antibody | Human | ELISA, WB, IHC, FC |
CSB-RA012719MA1HU | LAG3 Recombinant Monoclonal Antibody | Human | ELISA, IHC |
LAG3 Proteins for Homo sapiens (Human)
Code | Product Name | Source |
---|---|---|
CSB-YP012719HU1 CSB-BP012719HU1 CSB-MP012719HU1 CSB-EP012719HU1-B |
Recombinant Human Lymphocyte activation gene 3 protein (LAG3), partial | Yeast Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
CSB-CF012719HU | Recombinant Human Lymphocyte activation gene 3 protein (LAG3) | in vitro E.coli expression system |
CSB-EP012719HU1 | Recombinant Human Lymphocyte activation gene 3 protein (LAG3), partial | E.coli |
LAG3 ELISA Kit for Homo sapiens (Human)
Code | Product Name | Sample Types | Sensitivity |
---|---|---|---|
CSB-EL012719HU | Human Lymphocyte activation gene 3 protein(LAG3) ELISA kit | serum, plasma, tissue homogenates | 0.039 ng/mL |